Publication | Closed Access
Antimelanoma differentiation‐associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis
180
Citations
23
References
2016
Year
The anti-MDA5 antibody level is a novel parameter for monitoring and a good predictor of RP-ILD relapse in patients with CADM or DM.
| Year | Citations | |
|---|---|---|
Page 1
Page 1